Clarity Pharmaceuticals Ltd.
Clarity Pharmaceuticals Ltd. (CU6) is a clinical-stage radiopharmaceutical company specializing in the development of next-generation products for the treatment of cancer. The company operates in the biotechnology and pharmaceuticals sectors, focusing on the development of targeted theranostic radiopharmaceuticals that aim to improve cancer diagnosis and therapy. Clarity Pharmaceuticals leverages its proprietary SAR Technology platform to create a pipeline of innovative products designed to address unmet needs in oncology.